ATI RN
RN ATI Capstone Pharmacology 2 Quiz Questions
Question 1 of 5
A patient has been taking a beta blocker for 4 weeks as part of his antianginal therapy. He also has type II diabetes and hyperthyroidism. When discussing possible adverse effects, the nurse will include which information?
Correct Answer: D
Rationale: The correct information to include when discussing possible adverse effects of beta blockers with a patient who has type II diabetes and hyperthyroidism is to "Monitor your blood glucose levels for possible hypoglycemia or hyperglycemia." Beta blockers can mask the signs of hypoglycemia (low blood sugar) in patients with diabetes by suppressing the sympathetic nervous system response to low blood sugar. This can lead to a delay in recognizing and treating hypoglycemia, which can be dangerous for diabetic patients. Additionally, beta blockers can also affect glucose metabolism and potentially worsen hyperglycemia in patients with diabetes. Therefore, close monitoring of blood glucose levels is essential to manage these potential adverse effects and adjust the treatment regimen as needed.
Question 2 of 5
A patient has been diagnosed with angina and will be given a prescription for sublingual nitroglycerin tablets. When teaching the patient how to use sublingual nitroglycerin, the nurse will include which instruction?
Correct Answer: C
Rationale: When teaching a patient how to use sublingual nitroglycerin tablets, the nurse should include the instruction that if the chest pain is not relieved after one tablet, the patient should call 911 immediately. This is because persistent chest pain could indicate a more serious cardiac event, such as a myocardial infarction, that requires prompt medical attention. It is important for the patient to seek emergency help if the chest pain is not relieved after taking one sublingual nitroglycerin tablet. Taking multiple doses without relief of symptoms can be dangerous and delay appropriate medical intervention.
Question 3 of 5
During a blood transfusion, the patient begins to have chills and back pain. What is the nurse™s priority action?
Correct Answer: D
Rationale: The patient is exhibiting signs of a transfusion reaction, specifically indicating the possibility of a febrile non-hemolytic transfusion reaction. Chills and back pain are common symptoms of this type of reaction. The nurse's priority action in this situation is to discontinue the blood transfusion immediately to prevent further complications and potential harm to the patient. It is crucial to notify the prescriber promptly so that appropriate interventions can be initiated. Observing for other symptoms and slowing the infusion rate are important actions but may not be the priority in this scenario where the patient is experiencing signs of a possible transfusion reaction. It is not appropriate to tell the patient that these symptoms are a normal reaction, as they indicate a potential complication that needs immediate attention.
Question 4 of 5
Your patient is on the medication Lithium for bipolar I disorder. What major side effect should you monitor the patient for? ATI PHARMACOLOGY LATEST UPDATE 2022/2023 PROCTORED EXAM -STUDY GUIDE QUESTIONS & ANS 100% CORRECTLY VERIFIED GRADED A+ ATI PHARMACOLOGY LATEST UPDATE 2022/2023 PROCTORED EXAM -STUDY GUIDE QUESTIONS & ANS 100% CORRECTLY VERIFIED GRADED A+
Correct Answer: C
Rationale: One major side effect to monitor in a patient taking Lithium for bipolar I disorder is the risk of seizures. Lithium is known to lower the seizure threshold, increasing the likelihood of seizures occurring, especially if the patient has any pre-existing risk factors for seizures. Therefore, it is critical to closely monitor patients on Lithium for any signs or symptoms of seizures and promptly address them if they occur to prevent any complications. Monitoring lithium levels and maintaining them within the therapeutic range can also help reduce the risk of seizures.
Question 5 of 5
When giving digoxin (Lanoxin) to a patient, the health care provider notices various
Correct Answer: D
Rationale: Digoxin toxicity can lead to serious complications, such as arrhythmias and heart failure. Digibind, also known as digoxin immune fab, is a specific antidote used to treat severe cases of digoxin toxicity. It works by binding to digoxin in the body and forming a complex that is then excreted through the kidneys, effectively reversing the toxic effects of digoxin. Naloxone is used to reverse opioid overdose, Vitamin K is used to reverse warfarin overdose, and Fluemanzil is not a medication used for reversing digoxin toxicity.